ICTS-supported facility accelerates translation of promising research into improving outcomes for cancer and other related diseases

By •
""

Housed within the Siteman Cancer Center, the Biologic Therapy Core Facility (BTCF) partners with physicians and scientists to manufacture, characterize, and release complex, clinical-grade cell and gene therapy products, imaging agents, and other biologics to support early-phase clinical trials. The BTCF also supports cellular (e.g. hematopoietic stem cell selections) and tissue therapies (e.g. parathyroid cryopreservation) […]

ICTS hosts the 7th annual Symposium

By and •
Accelerating Translation: The Science of Moving Forward

The Washington University Institute of Clinical and Translational Sciences (ICTS) hosted its 7th Annual Symposium on Wednesday, May 7, 2025. This year’s theme, “Accelerating Translation: The Science of Moving Forward,” focused on differences between translational research and translational science and how projects can be adapted to overcome longstanding challenges along the research pipeline. The event was […]

WashU Investigator credits ICTS-related programs and funding mechanisms with career development and research advancement

By •
""

For James Krings, MD, MSCI, Assistant Professor of Medicine in the Division of Pulmonary & Critical Care, settling in at WashU for his career in scientific research seems always to have been written in the stars. Originally from St. Louis, MO, Krings returned home after attending medical school at Stanford University and completing his residency […]

Partnership Development and Sustainability Support Program (PDSS) 2025-2026 Awardees

By and •
""

The Center for Community Health Partnership and Research is pleased to announce three partnerships were selected to receive funding through the 2025-2026 Partnership Development and Sustainability Support (PDSS) program. PDSS awards provide up to $10,000 in funding for investigators and their community partner(s) to support their new or existing partnership efforts over a 12-month period. The […]

ICTS Announces 2025-2026 CTRFP Awardees

By •
""

WashU Institute of Clinical and Translational Sciences (ICTS) and The Foundation for Barnes-Jewish Hospital awards 18 investigators as part of the 18th annual Clinical and Translational Research Funding Program (CTRFP). The CTRFP is the largest internal grant funding program of the ICTS. Applicants are required to submit proposals for projects that promote the translation of […]

Next-gen Alzheimer’s drugs extend independent living by months (Links to an external site)

WashU Medicine News Release •
An Alzheimer’s patient with very mild symptoms who undergoes treatment with one of the new, next-generation therapies could expect to gain eight or 10 months living independently, according to a study by researchers at WashU Medicine. The new analysis interprets the benefits of the drugs in a way that is meaningful to patients and families, to help them make informed decisions about treatment.

In the past two years, the Food and Drug Administration has approved two novel Alzheimer’s therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease. But while the approvals of lecanemab and donanemab, both antibody therapies that clear plaque-causing amyloid proteins from the brain, were greeted with enthusiasm […]

ICTS Precision Health supports research on new genetic cause of neurodevelopmental disorders’

By •
Christina Gurnett, MD, PhD

Christina A. Gurnett, MD, PhD, A. Ernest and Jane G. Stein Professor of NeurologyHead, Division of Pediatric and Developmental Neurology Chief of Neurology, St. Louis Children’s Hospital, was recently published in the American Journal of Human Genetics. A cross-disciplinary team of researchers and physicians from Children’s National Hospital and WashU Medicine, in collaboration with physicians […]

WashU Investigator utilizes and nurtures community-based relationships to propel research and serve local communities

By •

For investigators, there is much to be considered when choosing how to conduct research projects. Which demographics will you target? Which funding mechanisms should you apply for? How long will it take you to accomplish your aims? One of the most important considerations that seems simple enough, though it can sometimes appear unfamiliar to investigators, […]

Trina W. turns plus size fitness into a plus size business

By and •
Trina Williams aka T-Will of Thick Chick Fitness

When Trina Williams was seven years old, she had a plan to be a schoolteacher for 20 years and then resign, which is exactly what she did. She couldn’t have seen how extensive her influence would be on fitness for Black plus size women through her brand Thick Chick Fitness. Her willingness to learn, face […]